186 related articles for article (PubMed ID: 38226976)
1. The effector program of human CD8 T cells supports tissue remodeling.
Delacher M; Schmidleithner L; Simon M; Stüve P; Sanderink L; Hotz-Wagenblatt A; Wuttke M; Schambeck K; Ruhland B; Hofmann V; Bittner S; Ritter U; Pant A; Helbich SS; Voss M; Lemmermann NA; Bessiri-Schake L; Bohn T; Eigenberger A; Menevse AN; Gebhard C; Strieder N; Abken H; Rehli M; Huehn J; Beckhove P; Hehlgans T; Junger H; Geissler EK; Prantl L; Werner JM; Schmidl C; Brors B; Imbusch CD; Feuerer M
J Exp Med; 2024 Feb; 221(2):. PubMed ID: 38226976
[TBL] [Abstract][Full Text] [Related]
2. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
[TBL] [Abstract][Full Text] [Related]
3. TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8
Ge Z; Zhou G; Campos Carrascosa L; Gausvik E; Boor PPC; Noordam L; Doukas M; Polak WG; Terkivatan T; Pan Q; Takkenberg RB; Verheij J; Erdmann JI; IJzermans JNM; Peppelenbosch MP; Kraan J; Kwekkeboom J; Sprengers D
Cell Mol Gastroenterol Hepatol; 2021; 12(2):443-464. PubMed ID: 33781741
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India.
Chandele A; Sewatanon J; Gunisetty S; Singla M; Onlamoon N; Akondy RS; Kissick HT; Nayak K; Reddy ES; Kalam H; Kumar D; Verma A; Panda H; Wang S; Angkasekwinai N; Pattanapanyasat K; Chokephaibulkit K; Medigeshi GR; Lodha R; Kabra S; Ahmed R; Murali-Krishna K
J Virol; 2016 Dec; 90(24):11259-11278. PubMed ID: 27707928
[TBL] [Abstract][Full Text] [Related]
5. The Amphiregulin/EGFR axis protects from lupus nephritis via downregulation of pathogenic CD4
Melderis S; Warkotsch MT; Dang J; Hagenstein J; Ehnold LI; Herrnstadt GR; Niehus CB; Feindt FC; Kylies D; Puelles VG; Berasain C; Avila MA; Neumann K; Tiegs G; Huber TB; Tharaux PL; Steinmetz OM
J Autoimmun; 2022 May; 129():102829. PubMed ID: 35468361
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice.
Chiu DK; Yuen VW; Cheu JW; Wei LL; Ting V; Fehlings M; Sumatoh H; Nardin A; Newell EW; Ng IO; Yau TC; Wong CM; Wong CC
Gastroenterology; 2020 Aug; 159(2):609-623. PubMed ID: 32275969
[TBL] [Abstract][Full Text] [Related]
7. A spontaneously arising pancreatic tumor does not promote the differentiation of naive CD8+ T lymphocytes into effector CTL.
Lyman MA; Aung S; Biggs JA; Sherman LA
J Immunol; 2004 Jun; 172(11):6558-67. PubMed ID: 15153470
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic Activity and Memory T Cell Subset Distribution of
Kuznetsova M; Lopatnikova J; Shevchenko J; Silkov A; Maksyutov A; Sennikov S
Front Immunol; 2019; 10():1017. PubMed ID: 31143180
[TBL] [Abstract][Full Text] [Related]
9. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
Wen T; Bukczynski J; Watts TH
J Immunol; 2002 May; 168(10):4897-906. PubMed ID: 11994439
[TBL] [Abstract][Full Text] [Related]
10. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients.
de la Barrera S; Finiasz DM; Fink S; Valdez R; Bottasso O; Balina LM; Sasiain MC
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):45-55. PubMed ID: 9207753
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-10 induces expression of CD39 on CD8+T cells to potentiate anti-PD1 efficacy in EGFR-mutated non-small cell lung cancer.
Qiao M; Zhou F; Liu X; Jiang T; Wang H; Jia Y; Li X; Zhao C; Cheng L; Chen X; Ren S; Liu H; Zhou C
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36543373
[TBL] [Abstract][Full Text] [Related]
12. Ly49D engagement on T lymphocytes induces TCR-independent activation and CD8 effector functions that control tumor growth.
Merck E; Voyle RB; MacDonald HR
J Immunol; 2009 Jan; 182(1):183-92. PubMed ID: 19109149
[TBL] [Abstract][Full Text] [Related]
13. Genetic Modification of CD8
Lozano T; Chocarro S; Martin C; Lasarte-Cia A; Del Valle C; Gorraiz M; Sarrión P; Ruiz de Galarreta M; Lujambio A; Hervás-Stubbs S; Sarobe P; Casares N; Lasarte JJ
Front Immunol; 2019; 10():2990. PubMed ID: 31921216
[TBL] [Abstract][Full Text] [Related]
14. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
[TBL] [Abstract][Full Text] [Related]
15. Association Between Expression Level of PD1 by Tumor-Infiltrating CD8
Kim HD; Song GW; Park S; Jung MK; Kim MH; Kang HJ; Yoo C; Yi K; Kim KH; Eo S; Moon DB; Hong SM; Ju YS; Shin EC; Hwang S; Park SH
Gastroenterology; 2018 Dec; 155(6):1936-1950.e17. PubMed ID: 30145359
[TBL] [Abstract][Full Text] [Related]
16. Functional heterogeneity of cytokines and cytolytic effector molecules in human CD8+ T lymphocytes.
Sandberg JK; Fast NM; Nixon DF
J Immunol; 2001 Jul; 167(1):181-7. PubMed ID: 11418647
[TBL] [Abstract][Full Text] [Related]
17. Amphiregulin inhibits TNF-α-induced alveolar epithelial cell death through EGFR signaling pathway.
Meng C; Wang S; Wang X; Lv J; Zeng W; Chang R; Li Q; Wang X
Biomed Pharmacother; 2020 May; 125():109995. PubMed ID: 32187954
[TBL] [Abstract][Full Text] [Related]
18. CD4
Perugino CA; Kaneko N; Maehara T; Mattoo H; Kers J; Allard-Chamard H; Mahajan VS; Liu H; Della-Torre E; Murphy SJH; Ghebremichael M; Wallace ZS; Bolster MB; Harvey LM; Mylvaganam G; Tuncay Y; Liang L; Montesi SB; Zhang X; Tinju A; Mochizuki K; Munemura R; Sakamoto M; Moriyama M; Nakamura S; Yosef N; Stone JH; Pillai S
J Allergy Clin Immunol; 2021 Jan; 147(1):368-382. PubMed ID: 32485263
[TBL] [Abstract][Full Text] [Related]
19. The Emerging Role of CD8
Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F
Front Immunol; 2018; 9():1904. PubMed ID: 30158938
[TBL] [Abstract][Full Text] [Related]
20. Partial agonism and independent modulation of T cell receptor and CD8 in hapten-specific cytotoxic T cells.
Preckel T; Breloer M; Kohler H; von Bonin A; Weltzien HU
Eur J Immunol; 1998 Nov; 28(11):3706-18. PubMed ID: 9842913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
